Inclusion Criteria:
To qualify for participation in this study, individuals must meet the following minimum criteria:

• Age 16 to 45 years (later on the study plans to enroll younger teens and children)
• Insulin dependent type 1-diabetes mellitus diagnosed within the previous 3 months
• At least one month from last immunization
• Willing to comply with intensive diabetes management
• If participant is a woman with reproductive potential, she must be willing to avoid pregnancy and have a negative pregnancy test
• Must weigh at least 25 kg at study entry
• Willing to forgo routine clinical immunizations during the first 100 days after initial study drug administration
  

Exclusion Criteria:
Individuals meeting any of the criteria below will not be eligible to participate in the study. Additional exclusion criteria may apply.

• Immunodeficiency or clinically significant chronic lymphopenia
• Pregnant or lactating or anticipating becoming pregnant for 24 months following first injection
• Serologic evidence of current or past HIV, Hep B, or Hep C infection
• Ongoing use of non-insulin pharmaceuticals to affect glycemic control
• Participation in another clinical trial with a new chemical entity within the past 3 months
• History of epilepsy, head trauma or cerebrovascular accident or clinical
• History of alcohol or drug abuse
  

'GAD' Trial Information:

Overview
A description of the rationale, design treatments used for the study

>> Eligibility <<
Inclusion and exclusion criteria for the study.

Locations & Contacts
Where the study is being conducted, with contact information.